OXYMETAZOLINE HYDROCHLORIDE by is a Otc medication manufactured, distributed, or labeled by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited. Drug facts, warnings, and ingredients follow.
2 or 3 sprays in each nostril not more than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
Shake well before use. Before using the first time, remove the protective cap from the tip and prime metered pump by depressing firmly several times. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depress pump all the way down with a firm even stroke and sniff deeply. Wipe nozzle clean after use.
NDC: 68382-418-07
Oxymetazoline Hydrochloride Concentrated Vapor Nasal Spray, ¾ FL OZ (22 mL)
Rx only
Zydus
OXYMETAZOLINE HYDROCHLORIDE
oxymetazoline hydrochloride spray, metered |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
Labeler - Zydus Pharmaceuticals (USA) Inc. (156861945) |
Registrant - Zydus Pharmaceuticals (USA) Inc. (156861945) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Cadila Healthcare Limited | 918596198 | Analysis, Manufacture |